Josh Cohen

Josh Cohen is the Co-CEO and Co-Founder at Amylyx Pharmaceuticals Inc. where he has invented and developed AMX0035 and brought it through clinical trials with the help of Justin Klee his co-founder and the other Co-CEO at Amylyx as well as with help from their team and the ALS and Alzheimer's Communities who have guided us and advised us at every step of the way.
Country: USA
Visit Website